---
$id: https://graph.org.ai/products/commodity/51171636
$type: Product
source: UNSPSC
code: "51171636"
title: "Danthron or dantron"
class: "51171600"
classTitle: "Laxatives"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Danthron or dantron

**UNSPSC Code**: 51171636
**Class**: [Laxatives](Laxatives.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a carcinogenic anthraquinone with the molecular formula C14H8O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z4XE6IBF3V, chemically known as 1,4,5,8-tetroxyantraquinone but generally known as danthron, which bears US NIH Compound Identifier 2950. European Medicines Agency schedules Danthron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06904MIG. The term DANTRON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules danthron in its Anatomical Therapeutic Chemical (ATC) Classification. Danthron or dantron bears US NLM identifiers UMLS ID C0057135 and NCI Concept Code C44363. SMILES: O=C1C2C(C(=O)C3C1C(O)CCC3)CCCC2O.

